H E R C PRODUCTS INC
10QSB, 1998-08-13
SPECIALTY CLEANING, POLISHING AND SANITATION PREPARATIONS
Previous: SMITH CHARLES E RESIDENTIAL REALTY INC, S-3, 1998-08-13
Next: BIOSEPRA INC, 10-Q, 1998-08-13



                     U.S. SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549

                                   Form 10-QSB


(X) QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
    1934:   For  the  Quarterly Period Ended June 30, 1998

( ) TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE EXCHANGE ACT  
    For the transition period from __________ to ____________.


                         Commission File Number 1-13012

                         H.E.R.C. PRODUCTS INCORPORATED
           (Name of small business issuer as specified in its charter)

<TABLE>
<S>                                                    <C>       
State of Incorporation: Delaware                       IRS Employer Identification Number: 86-0570800
</TABLE>


                          2202 W Lone Cactus Drive #15
                             Phoenix, Arizona 85027
                    (Address of principal executive offices)

                                 (602) 492-0336
                           (Issuer's telephone number)

Check  whether the issuer (1) filed all reports  required to be filed by Section
13 or 15(d) of the Securities Exchange Act of 1934 during the past 12 months (or
for such shorter  period that the registrant was required to file such reports),
and (2) has been subject to such filing requirements for the past 90 days.

                              YES    X           NO  
                                  -------            ------- 

State the number of shares outstanding of each of the issuer's classes of common
equity, as of the latest practicable date.

                                                         Outstanding at
                                                         --------------
                      Class                              August 4, 1998
                      -----                              --------------


               Common Stock, $.01 par value                 11,470,588


Transitional Small Business Development Format:

                                           YES _______   NO ______X___
<PAGE>
                 H.E.R.C. PRODUCTS INCORPORATED AND SUBSIDIARIES


Index To Consolidated Financial Statements

PART I. FINANCIAL INFORMATION                                           Page No.

        Consolidated Financial Statements:
        Consolidated Balance Sheets
               June 30, 1998 and December 31, 1997                            3
        Consolidated Statements of Operations
               Three Months and Six Months  Ended June 30, 1998 and 1997      4
        Consolidated Statement of Stockholders' Equity
               Six Months Ended June 30, 1998                                 5
        Consolidated Statements of Cash Flows
               Six Months Ended June 30, 1998 and 1997                        6

        Notes to Consolidated Financial Statements                            7

        Management's Discussion and Analysis of Financial
               Condition and Results of Operations                            9


PART II.  OTHER INFORMATION

        Item 2 - Changes in Securities                                       11

        Item 5 - Other Information                                           11

        Item 6 - Exhibits and Reports on Form 8-K                            12
<PAGE>
                 H.E.R.C. PRODUCTS INCORPORATED AND SUBSIDIARIES

                           Consolidated Balance Sheets
<TABLE>
<CAPTION>
                                                                                      June 30,       December 31,
                                                                                        1998            1997
                                                                                    ------------    ------------
                                                                                     (Unaudited)
<S>                                                                                 <C>             <C>         
Assets
Current Assets
     Cash and cash equivalents                                                      $    475,064    $    135,396
     Trade accounts receivable, net of allowance for
           doubtful accounts of $20,646 and $36,205 respectively                         577,773         166,751
     Inventories, principally finished goods                                             158,729          87,738
     Other receivables                                                                    17,231          11,963
     Prepaid expenses                                                                    158,161          98,757
                                                                                    ------------    ------------
           Total Current Assets                                                        1,386,958         500,605
                                                                                    ------------    ------------

Property and Equipment
     Property and equipment                                                            1,140,705       1,057,470
           Less accumulated depreciation                                                 316,962         235,253
                                                                                    ------------    ------------
           Net Property and Equipment                                                    823,743         822,217
                                                                                    ------------    ------------

Other Assets
     Patents, net of accumulated amortization of $97,039 and $93,789 respectively         58,450          62,642
     Patents pending                                                                      92,210          71,146
     Refundable deposits and other assets                                                109,364          93,021
     Goodwill, net of accumulated amortization of $10,867 and $8,150 respectively         97,802         100,519
                                                                                    ------------    ------------
            Total Other Assets                                                           357,826         327,328
                                                                                    ------------    ------------
                                                                                    $  2,568,527    $  1,650,150
                                                                                    ============    ============

Liabilities and Stockholders' Equity
Current Liabilities
     Accounts payable                                                               $    340,906    $    583,571
     Accrued wages                                                                        67,660          91,450
     Current portion of notes payable                                                    350,741         287,856
     Net liabilities of discontinued operation                                           329,930         261,272
     Other accrued expenses                                                              293,795         110,928
                                                                                    ------------    ------------
            Total Current Liabilities                                                  1,383,032       1,335,077
                                                                                    ------------    ------------

Long-Term Liabilities
     Notes payable, net of current portion                                                50,908          66,938
                                                                                    ------------    ------------
            Total Liabilities                                                          1,433,940       1,402,015
                                                                                    ------------    ------------

Stockholders' Equity
     Common Stock, $0.01 par value; authorized 40,000,000 shares;
            issued and outstanding 11,470,588  and 8,230,588 shares respectively         114,706          82,306
     Additional paid-in capital                                                       13,918,006      12,947,406
     Accumulated deficit                                                             (12,898,125)    (12,781,577)
                                                                                    ------------    ------------
            Total Stockholders' Equity                                                 1,134,587         248,135
                                                                                    ------------    ------------
                                                                                    $  2,568,527    $  1,650,150
                                                                                    ============    ============
</TABLE>
See accompanying notes to consolidated financial statements
                                                                               3
<PAGE>
                 H.E.R.C. PRODUCTS INCORPORATED AND SUBSIDIARIES

                      Consolidated Statements of Operations
                                   (Unaudited)
<TABLE>
<CAPTION>
                                                     Three Months Ended June 30,      Six Months Ended June 30,
                                                         1998           1997             1998            1997
                                                         ----           ----             ----            ----
<S>                                                  <C>             <C>             <C>             <C>         
Sales                                                $  1,157,174    $    744,266    $  2,138,973    $  1,549,810
Cost of Sales                                             610,011         692,795       1,101,049       1,263,577
                                                     ------------    ------------    ------------    ------------
Gross Profit                                              547,163          51,471       1,037,924         286,233
Selling Expenses                                          147,102         229,776         283,195         489,129
General and Administrative Expenses                       408,143         554,901         837,855       1,319,111
                                                     ------------    ------------    ------------    ------------
Operating Loss                                             (8,082)       (733,206)        (83,126)     (1,522,007)
                                                     ------------    ------------    ------------    ------------
Other Income (Expense)
   Interest expense                                       (32,605)         (3,759)        (57,396)         (5,634)
   Miscellaneous                                              997           5,862           1,377          23,769
   Expenses relating to settlement of lawsuits            (55,000)           --           (55,000)           --
   Gain on sale of patent                                    --              --            77,597            --
                                                     ------------    ------------    ------------    ------------
         Total Other Income (Expense)                     (86,608)          2,103         (33,422)         18,135
                                                     ------------    ------------    ------------    ------------
Loss from Continuing Operations                           (94,690)       (731,103)       (116,548)     (1,503,872)
Income from Operations of Discontinued Segment               --           118,962            --            40,856
                                                     ------------    ------------    ------------    ------------
Net Loss                                                  (94,690)       (612,141)       (116,548)     (1,463,016)
Non-Cash Dividend on Preferred Stock                         --            10,707            --            62,842
                                                     ------------    ------------    ------------    ------------
Net Loss Allocable to Common Stockholders            $    (94,690)   $   (622,848)   $   (116,548)   $ (1,525,858)
                                                     ============    ============    ============    ============

Loss Per Common Share - Basic & Diluted
- ---------------------------------------

Loss from Continuing Operations                      $      (0.01)   $      (0.09)   $      (0.01)   $      (0.21)
Income from Operations of Discontinued Segment               --              0.01            --              0.00
                                                     ------------    ------------    ------------    ------------
Net Loss Per Common Share                            $      (0.01)   $      (0.08)   $      (0.01)   $      (0.21)

Weighted Average Common Shares Outstanding             10,342,896       8,037,399       9,292,577       7,309,746
                                                     ============    ============    ============    ============
</TABLE>
See accompanying note to consolidated financial statements.
                                                                               4
<PAGE>
                 H.E.R.C. PRODUCTS INCORPORATED AND SUBSIDIARIES

                 Consolidated Statement of Stockholders' Equity
                                   (Unaudited)
<TABLE>
<CAPTION>

                                             Common Stock            Additional
                                                                      Paid-in     Accumulated
                                         Shares        Amount         Capital       Deficit             Total
                                         ------        ------         -------       -------             -----

<S>                                     <C>         <C>            <C>            <C>             <C>         
Balance,
January 1, 1998                         8,230,588   $     82,306   $ 12,947,406   $(12,781,577)   $    248,135

Net loss                                     --             --             --         (116,548)       (116,548)

Warrants issued for services                 --             --            3,600           --             3,600

Issuance of shares of Common Stock      3,240,000         32,400        967,000           --           999,400
                                       ----------   ------------   ------------   ------------    ------------

Balance,
June 30, 1998                          11,470,588   $    114,706   $ 13,918,006   $(12,898,125)   $  1,134,587
                                       ----------   ------------   ------------   ------------    ------------
</TABLE>
See accompanying notes to consolidated financial statements.
                                                                               5
<PAGE>
                 H.E.R.C. PRODUCTS INCORPORATED AND SUBSIDIARIES

                      Consolidated Statements of Cash Flows
                                   (Unaudited)

<TABLE>
<CAPTION>
                                                                                     Six Months Ended June 30,
                                                                                        1998           1997
                                                                                        ----           ----
<S>                                                                                 <C>            <C>         
Cash Flows From Operating Activities                                                
         Net Loss                                                                   $  (116,548)   $(1,463,016)
                                                                                    -----------    -----------
         Adjustments to reconcile net loss to net cash                              
             used in operating activities                                           
            Depreciation and amortization                                               164,874        138,000
            Change in net liabilities of discontinued operation                          68,658           --
            Loss on sale or disposal of equipment                                         5,696          3,255
            (Increase) decrease in assets                                           
                Trade accounts receivable                                              (411,022)      (281,444)
                Inventories                                                             (70,991)        25,629
                Other receivables                                                        (5,268)         3,058
                Prepaid expenses                                                        (90,604)       (69,800)
                Other assets                                                            (54,346)        11,401
            Increase (decrease) in liabilities                                      
                Accounts payable                                                       (242,665)       392,433
                Accrued expenses                                                        159,077        130,153
                Other liabilities                                                          --          226,798
                                                                                    -----------    -----------
                    Total adjustments                                                  (476,591)       579,483
                                                                                    -----------    -----------
                         Net cash used in operating activities                         (593,139)      (883,533)
                                                                                    -----------    -----------
Cash Flows From Investing Activities                                                
        Capital expenditures                                                            (98,562)      (212,275)
        Cash received from the sale of equipment                                          7,005           --
        Expenditures related to patents and patents pending                             (21,891)       (89,352)
                                                                                    -----------    -----------
                         Net cash used in investing activities                         (113,448)      (301,627)
                                                                                    -----------    -----------
Cash Flows From Financing Activities                                                
        Proceeds from issuance of Common Stock                                          999,400           --
        Proceeds from exercise of stock options                                            --           19,375
        Proceeds from exercise of warrant                                                  --          140,250
        Proceeds from issuance of notes payable                                     
          and long-term debt                                                            125,470           --
        Private offering costs                                                             --          (30,393)
        Principal payments under notes payable                                          (78,615)       (14,805)
                                                                                    -----------    -----------
                         Net cash provided by financing activities                    1,046,255        114,427
                                                                                    -----------    -----------
Net increase (decrease) in cash and cash equivalents                                    339,668     (1,070,733)
Cash and cash equivalents at beginning of period                                        135,396      1,369,843
                                                                                    -----------    -----------
Cash and cash equivalents at end of period                                          $   475,064    $   299,110
                                                                                    ===========    ===========
                                                                                    
Supplemental Disclosures of Cash Flow Information                                   
Cash paid during the period for interest                                            $    57,396    $     7,423
                                                                              
During 1997, 1,714,101 shares of Common Stock were issued upon the conversion of 170,000 shares of Preferred Stock. 
During 1997, certain adjustments were made to assets and liabilities acquired in the purchase of the 50% interest of
     H.E.R.C.  Consumer Products Company and, accordingly,  goodwill was reduced by $22,673.  
During 1997, inventory with a value of $211,685 was reclassified to property and equipment.  
During 1998, the value attributed to warrants issued to prepay future expenses was $3,600.
</TABLE>

See accompanying notes to consolidated financial statements.
                                                                               6
<PAGE>
                 H.E.R.C. PRODUCTS INCORPORATED AND SUBSIDIARIES

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                   (Unaudited)


NOTE 1 - Basis of Presentation

The unaudited consolidated financial statements are presented in accordance with
the  requirements  of Form  10-QSB and  consequently  do not  include all of the
disclosures  normally  made in an annual Form 10-KSB  filing.  Accordingly,  the
consolidated financial statements of H.E.R.C.  Products Incorporated ("Company")
included  herein  should  be  reviewed  in  conjunction  with  the  consolidated
financial  statements  and  the  accompanying   footnotes  included  within  the
Company's Form 10-KSB for the year ended December 31, 1997.

The consolidated  financial statements have been prepared in accordance with the
Company's  customary  accounting  practices  and have not been  audited.  In the
opinion  of  management,  the  consolidated  financial  statements  reflect  all
adjustments  necessary to report  fairly the  Company's  financial  position and
results of operations for the interim  period.  All such  adjustments are normal
and recurring in nature. The interim  consolidated results of operations are not
necessarily  indicative  of results to be expected for the year ending  December
31, 1998.

NOTE 2 - Inventories

Inventories  are stated at the lower of cost or market (net  realizable  value).
Cost is determined by various methods which approximate first-in, first-out.

NOTE 3 - Long Term Debt and Other Financing Arrangements

In  September  1997,  the Company  closed on a five year term loan and  borrowed
$250,000.  Interest  is  payable  monthly  at an annual  rate of 14%;  principal
repayments are over 54 months and begin 6 months after take-down.  In connection
with the closing of such loan,  the Company  issued two  warrants to the lender,
each to  purchase  62,500  shares  of  Common  Stock at $1.18  (market  price at
closing) and $1.475 (25%  premium  over market price at closing),  respectively.
The Company may prepay the loan;  certain  fees and  conditions,  including  the
issuance of two identical  warrants,  apply if prepayment is not made within two
years of takedown.

At June 30, 1998, the Company is not in compliance with certain covenants in the
loan agreement;  accordingly,  the total indebtedness is classified as a current
liability in the accompanying Consolidated Balance Sheets.

In October 1997, the Company  concluded  arrangements  for a factoring  facility
whereby 80% of a maximum of $600,000 in eligible  receivables may be financed at
an effective annual interest rate of approximately  16%. The initial term of the
facility is two years which may be extended.

Substantially  all of the Company's  assets are pledged as security  pursuant to
the above agreements.

                                                                               7
<PAGE>
                 H.E.R.C. PRODUCTS INCORPORATED AND SUBSIDIARIES

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                   (Unaudited)


NOTE 4 - Stockholders' Equity

During the second quarter of 1998,  the Company sold 3,240,000  shares of Common
Stock at $0.31 per share and received net proceeds of $999,400.



NOTE 5 - Discontinued Operation

During the fourth quarter of 1997, the Company determined that it would exit the
agricultural  business and commenced efforts to dispose of its investment in its
wholly  owned  subsidiary,  CCT  Corporation,   which  is  accounted  for  as  a
discontinued  operation in the accompanying  financial statements.  Accordingly,
the  Consolidated  Statements of Operations  for the three months and six months
ended June 30, 1997 are reclassified.

                                                                               8
<PAGE>
                 H.E.R.C. PRODUCTS INCORPORATED AND SUBSIDIARIES
                Management's Discussion and Analysis of Financial
                       Condition and Results of Operations

Forward-Looking Statements
- --------------------------

When used in this Form  10-QSB  and in future  filings by the  Company  with the
Securities and Exchange Commission ("SEC") , in the Company's press releases and
in oral statements made with the approval of an authorized  executive officer of
the Company,  the words or phrases "are  expected",  "the Company  anticipates",
"will continue",  "believe",  "project",  "estimated", "will enhance" or similar
expressions  (including  confirmations by an authorized executive officer of the
Company  of any such  expressions  made by a third  party  with  respect  to the
Company)  are  intended  to  identify  "forward-looking  statements"  within the
meaning of that term in Section 27A of the  Securities  Act of 1933,  as amended
("the Act"), and Section 21E of the Securities  Exchange Act of 1934 as amended.
Readers are  cautioned not to place undue  reliance on any such  forward-looking
statements,  each of which speak only as of the date made.  Such  statements are
subject to certain risks and  uncertainties  that could cause actual  results to
differ  materially from historical  earnings and those currently  anticipated or
projected.  Such risks include, but are not limited to, (i) a history of losses,
accumulated  deficit and  periodically  inadequate  cash flow, (ii) the possible
need  for  additional  financing,  (iii) a  competitive  market  for some of its
products,  (iv) the need to expand its  marketing  program,  (v) limited  market
acceptance of its industrial products and (vi) dependence on a limited number of
customers.  The Company has no obligation to publicly  release the result of any
revisions  which may be made to any  forward-looking  statements  to reflect any
anticipated events or circumstances occurring after the date of such statements.

This  discussion  and analysis of financial  condition and results of operations
should  be  read  in  conjunction  with  the  unaudited  consolidated  financial
statements and the related disclosures included elsewhere herein.

Results of Operations
- ---------------------

Three Months Ended June 30, 1998 Compared to Three Months Ended June 30, 1997
- -----------------------------------------------------------------------------

         Sales of $1,157,000  during the second quarter of 1998 are 55% ahead of
1997 second quarter sales of $744,000.  The increase reflects substantial growth
in  Industrial  Products  sales.  Industrial  Products  sales were  $862,000 and
$363,000 in 1998 and 1997  respectively.  The  increase in  Industrial  Products
revenue is attributable to the continuing expansion of the Company's marine ship
pipe line chemical cleaning services.  The Company anticipates  continued growth
in marine revenue for the remainder of the year and into 1999. Consumer Products
sales  decreased  from  $381,000 in 1997 to  $295,000  in 1998 due to  increased
competition.

         Consolidated   gross   margins  were  47%  and  7%  in  1998  and  1997
respectively.  Gross margin for Industrial  Products of 53% in 1998 was a result
of increased revenue from marine ship cleaning. Consumer Products margin was 31%
in 1998 compared to 35% in 1997.

         Gross profit increased from $51,000 in 1997 to $547,000 in 1998 because
a larger  percentage of revenue came from the higher margin industrial work that
the company has been focussing on growing.  Loss from continuing  operations was
$95,000 in 1998  compared to $731,000 in 1997  because of a decrease of $229,000
in aggregate  selling,  general and  administrative  expenses  combined with the
above increase in gross profit. The decrease in aggregate  selling,  general and
administrative  expenses is a function of the Company's cost containment program
implemented  in the third quarter of 1997. Net loss was $94,690 in 1998 compared
to $612,141  in 1997.  The 1997 net loss  includes  income  from  operations  of
discontinued segment of $118,962.

                                                                               9
<PAGE>
                 H.E.R.C. PRODUCTS INCORPORATED AND SUBSIDIARIES
                Management's Discussion and Analysis of Financial
                 Condition and Results of Operations (Continued)

Six Months Ended June 30, 1998 Compared to Six Months Ended June 30, 1997
- -------------------------------------------------------------------------

         Sales of $2,139,000 during the first half of 1998 are 38% ahead of 1997
sales of $1,550,000.  Industrial  Products sales were $1,460,000 and $542,000 in
1998 and 1997  respectively,  reflecting  an increase of 169%.  The  increase in
Industrial  Products revenue is attributable to the continuing  expansion of the
Company's marine ship pipe line chemical  cleaning  services.  Consumer products
sales  decreased  from  $1,008,000  in 1997 to $679,000 in 1998 due to increased
competition and loss of market share.

         Consolidated   gross  margins  were  49%  and  18%  in  1998  and  1997
respectively.  Industrial  Products margin increased to 59% because of the shift
in revenue from  municipal  potable water pipe cleaning to marine ship pipe line
cleaning,  fire  protection  system  cleaning  and  industrial  chemical  sales.
Consumer Products margin was 26% in 1998 compared to 27% in 1997.

         Gross profit  increased  from  $286,000 in 1997 to  $1,038,000  in 1998
while  aggregate  selling,  general and  administrative  expenses  decreased  by
$687,000  resulting  in a loss from  continuing  operations  of $117,000 in 1998
compared  to  $1,504,000  in  1997.  The  reduction  in  selling,   general  and
administrative expenses is directly attributable to the cost containment program
put into  place in the third  quarter  of 1997.  Net loss was  $116,548  in 1998
compared  to  $1,463,016  in  1997.  The  1997 net  loss  includes  income  from
operations of discontinued segment of $40,856.

Liquidity and Capital Resources
- -------------------------------

         Cash and cash  equivalents  were $475,000 and $135,000 at June 30, 1998
and December 31, 1997 respectively  while working capital was $4,000 compared to
a working capital deficit of $834,000 at those respective dates. The increase in
working  capital is a  function  of the sale of Common  Stock  offset by the net
loss.

         In the second  quarter of 1998,  the Company sold  3,240,000  shares of
Common Stock at $0.31 per share and received net proceeds of $999,400.

         As of June 30, 1998 , the Company was not in  compliance  with  certain
covenants pertaining to its term loan. However, all payments required to service
the debt have been made on a timely  basis and the lender has taken no action to
accelerate repayment of principal.

         Through the first half of 1998,  the Company was able to generate  cash
flow necessary to support its ongoing  business.  The Company  instituted a cost
containment program for its selling,  general and administrative expenses during
the third quarter of 1997 and will  continue to look for ways to contain  costs.
Management  cannot  assure that  financial  results for the balance of 1998 will
provide sufficient positive cash flow to fund ongoing operations.

         Although the Company has sought to contain  costs and its revenues have
improved  during the first six months of 1998,  the  financial  condition of the
Company may not be able to sustain  operations on a current basis because of its
dependence on a limited  industrial  business which is relatively new. Moreover,
sales of its consumer  products remain at low levels due to the  competitiveness
of the business,  the  comparable  cost and limited  marketing  resources of the
Company.  The Company has required regular financings to continue its operations
and  anticipates  it may need further  financing in the future.  There can be no
assurance  that the Company will be able to sell  additional  securities  in the
future or borrow needed funds.  Substantially  all the assets of the Company are
pledged for its loan and receivables  financings.  To the extent that any future
financing involves the sale of the Company's equity securities,  the interest of
the Company's then stockholders could be substantially diluted.

         The Company has  received  notification  from its provider of financial
and accounting software that such software is structured to accommodate the year
2000 and beyond.

                                                                              10
<PAGE>
PART II: OTHER INFORMATION


Item 2. Changes in Securities

Recent Sales of Unregistered Securities

During the second quarter of 1998,  the Company sold 3,240,000  shares of Common
Stock at $0.31  per share  pursuant  to an  exemption  from  registration  under
Section  4(2) of the  Securities  Act of  1933  and  received  net  proceeds  of
$999,400.

During the second quarter of 1998,  the Company  issued to its employees,  under
the 1996 Equity  Performance Plan,  options to purchase 208,500 shares of Common
Stock at the exercise  price of $0.3125 per share  pursuant to an exemption from
registration  under Section 4(2) of the  Securities  Act of 1933 and received no
proceeds on the grants.

During the second  quarter of 1998,  the  Company,  upon  cancellation  of prior
options,  granted repriced options to purchase 525,000 shares of Common Stock at
exercise prices ranging from $0.31 to $0.3125 per share pursuant to an exemption
from registration  under Section 4(2) of the Securities Act of 1933 and received
no proceeds on the grants.

During the second  quarter of 1998,  the  Company,  upon  cancellation  of prior
warrants,  granted repriced  warrants to purchase 227,583 shares of Common Stock
at  exercise  prices  ranging  from  $0.31 to $0.45  per  share  pursuant  to an
exemption from registration under Section 4(2) of the Securities Act of 1933 and
received no proceeds on the grants.

Item 5. Other Information

Notice to Stockholders Regarding 1999 Annual Meeting of Stockholders:

         Pursuant  to Rule 14a-4  promulgated  by the  Securities  and  Exchange
Commission,  stockholders  are advised  that the  Company's  management  will be
permitted to exercise  discretionary  voting authority under proxies it solicits
and obtains for the Company's 1999 Annual Meeting of  Stockholders  with respect
to any  proposal  presented  by a  stockholder  at  such  meeting,  without  any
discussion  of the proposal in the Company's  proxy  statement for such meeting,
unless the Company  receives notice of such proposal at its principal  office in
Phoenix, Arizona not later than May 18, 1999.

                                                                              11
<PAGE>
Item 6. Exhibits and Reports on Form 8-K

Reports on Form 8-K: None



Exhibits

Regulation S-B
Exhibit No. Exhibit
- ---------------------------

(27)       Financial Data Schedule


Signatures

Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
Registrant has duly caused this  Quarterly  Report to be signed on its behalf by
the undersigned, thereunto duly authorized.



                                             H.E.R.C. PRODUCTS INCORPORATED
                                             ------------------------------
                                                      (Registrant)


Date: August 13, 1998                     By:    /s/ S. Steven Carl             
                                            ------------------------------------
                                                 S. Steven Carl
                                                 Chief Executive Officer

                                          By:    /s/ Michael H. Harader     
                                            ------------------------------------
                                                 Michael H. Harader
                                                 Chief Accounting Officer

                                                                              12

<TABLE> <S> <C>

<ARTICLE>                             5
<MULTIPLIER>                          1
<CURRENCY>                            U.S. DOLLARS
       
<S>                                   <C>
<PERIOD-TYPE>                         6-MOS
<FISCAL-YEAR-END>                                           DEC-31-1998
<PERIOD-START>                                              JAN-01-1998
<PERIOD-END>                                                JUN-30-1998
<EXCHANGE-RATE>                                             1
<CASH>                                                      475,064
<SECURITIES>                                                0
<RECEIVABLES>                                               598,419
<ALLOWANCES>                                                20,646
<INVENTORY>                                                 158,729
<CURRENT-ASSETS>                                            1,386,958
<PP&E>                                                      1,140,705
<DEPRECIATION>                                              316,962
<TOTAL-ASSETS>                                              2,568,527
<CURRENT-LIABILITIES>                                       1,383,032
<BONDS>                                                     0
                                       0
                                                 0
<COMMON>                                                    114,706
<OTHER-SE>                                                  1,019,881
<TOTAL-LIABILITY-AND-EQUITY>                                2,568,527
<SALES>                                                     2,138,973
<TOTAL-REVENUES>                                            2,138,973
<CGS>                                                       1,101,049
<TOTAL-COSTS>                                               2,222,099
<OTHER-EXPENSES>                                            (23,974)
<LOSS-PROVISION>                                            0
<INTEREST-EXPENSE>                                          57,396
<INCOME-PRETAX>                                             (116,548)
<INCOME-TAX>                                                0
<INCOME-CONTINUING>                                         (116,548)
<DISCONTINUED>                                              0
<EXTRAORDINARY>                                             0
<CHANGES>                                                   0
<NET-INCOME>                                                (116,548)
<EPS-PRIMARY>                                               (0.01)
<EPS-DILUTED>                                               (0.01)
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission